NCT07502963Not yet recruiting
Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer
Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer: Randomized Clinical Trial.
Source: ClinicalTrials.gov · Last updated 31 Mar 2026
Brief summary (registry, in English)
This clinical study evaluates whether a supervised, multimodal therapeutic exercise program started before chemotherapy and continued during treatment can improve treatment outcomes in patients aged 35 to 65 years with breast, lung, or colon cancer. The study hypothesis is that participation in this exercise program improves tolerance to chemotherapy, allowing patients to receive more than 85% of the planned relative dose intensity. In addition, the program is expected to enhance treatment effectiveness by increasing the rate of complete radiological response. The main objective of the study is to assess the effectiveness of a supervised, multimodal therapeutic exercise program performed before and during chemotherapy in improving both treatment tolerance and treatment efficacy in patients with breast, lung, and colon cancer.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 4 Mar 2026
- Start date
- Apr 2026
- Primary completion date
- Apr 2027
- Lead sponsor
- University of Vic - Central University of Catalonia
- Diseases
- Lung cancer, Colorectal cancer
- NCT number
- NCT07502963
What you commit to
- Study type: Interventional
- Planned participants: 70
- From Apr 2026 to the primary completion date, Apr 2027
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Musculoskeletal or neurological disorders that prevent proper execution of the exercises
- Uncontrolled infections or symptoms
- Comorbidities such as chronic obstructive pulmonary disease (COPD), respiratory failure, or recent cardiovascular events within the past 6 months
Other
- Body mass index (BMI) over 35
- Pregnant women
- Difficulty understanding the purpose and procedures of the study
Who the study is looking for
- Women and men aged 35 to 65 years
- Diagnosed with stage II, III, or IV breast, lung, or colon cancer
- Scheduled to start neoadjuvant chemotherapy
- Able and willing to provide written informed consent
Age in the registry: 35 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitari de la Santa Creu Coordinator of this site? Confirm its status | Vic | Spain | Unknown status |
| Facultat de Ciències de la Salut i del Benestar de la Universitat de Vic (UVIC-UCC) Universitat de Vic- Universitat Central de Catalunya Coordinator of this site? Confirm its status | Vic | Spain | Unknown status |
| Consorci Hospitalari de Vic Coordinator of this site? Confirm its status | Vic | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.